TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials January 27, 2012
TCL Archive In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle June 2, 1989